Works matching IS 03065251 AND DT 1983 AND VI 16 AND IP 2
1
- British Journal of Clinical Pharmacology, 1983, v. 16, n. 2, p. 175, doi. 10.1111/j.1365-2125.1983.tb04982.x
- Article
2
- British Journal of Clinical Pharmacology, 1983, v. 16, n. 2, p. 127, doi. 10.1111/j.1365-2125.1983.tb04975.x
- Potts, RC;
- MacConnachie, A.;
- Brown, RA;
- Gibbs, JH;
- Robertson, AJ;
- Hassan, HA;
- Beck, JS
- Article
3
- British Journal of Clinical Pharmacology, 1983, v. 16, n. 2, p. 195, doi. 10.1111/j.1365-2125.1983.tb04986.x
- Feely, J.;
- Clee, M.;
- Pereira, L.;
- Guy, E.
- Article
4
- British Journal of Clinical Pharmacology, 1983, v. 16, n. 2, p. 149, doi. 10.1111/j.1365-2125.1983.tb04979.x
- Stacher, G.;
- Steinringer, H.;
- Winklehner, S.;
- Mittelbach, G.;
- Schneider, C.
- Article
5
- British Journal of Clinical Pharmacology, 1983, v. 16, n. 2, p. 167, doi. 10.1111/j.1365-2125.1983.tb04981.x
- Article
6
- British Journal of Clinical Pharmacology, 1983, v. 16, n. 2, p. 121, doi. 10.1111/j.1365-2125.1983.tb04974.x
- Hedner, T.;
- Persson, B.;
- Berglund, G.
- Article
7
- British Journal of Clinical Pharmacology, 1983, v. 16, n. 2, p. 191, doi. 10.1111/j.1365-2125.1983.tb04985.x
- Levy, M.;
- Eldor, A.;
- Zylber-Katz, E.;
- Eliakim, M.
- Article
8
- British Journal of Clinical Pharmacology, 1983, v. 16, n. 2, p. 145, doi. 10.1111/j.1365-2125.1983.tb04978.x
- Meyer, BH;
- Muller, FO;
- Clur, BK;
- Grigoleit, HG
- Article
9
- British Journal of Clinical Pharmacology, 1983, v. 16, n. 2, p. 201, doi. 10.1111/j.1365-2125.1983.tb04989.x
- Article
10
- British Journal of Clinical Pharmacology, 1983, v. 16, n. 2, p. 157, doi. 10.1111/j.1365-2125.1983.tb04980.x
- Devonshire, HW;
- Kong, I.;
- Cooper, M.;
- Sloan, TP;
- Idle, J.R.;
- Smith, RL
- Article
11
- British Journal of Clinical Pharmacology, 1983, v. 16, n. 2, p. 117, doi. 10.1111/j.1365-2125.1983.tb04973.x
- Dunk, AA;
- Jenkins, WJ;
- Burroughs, AK;
- Walt, RP;
- Osuafor, TO;
- Sherlock, S.;
- Mackie, S.;
- Dick, R.
- Article
12
- British Journal of Clinical Pharmacology, 1983, v. 16, n. 2, p. 188, doi. 10.1111/j.1365-2125.1983.tb04984.x
- Jack, DB;
- Wilkins, M.;
- Quarterman, CP
- Article
13
- British Journal of Clinical Pharmacology, 1983, v. 16, n. 2, p. 139, doi. 10.1111/j.1365-2125.1983.tb04977.x
- Montgomery, I.;
- Oswald, I.;
- Morgan, K.;
- Adam, K.
- Article
14
- British Journal of Clinical Pharmacology, 1983, v. 16, n. 2, p. 200, doi. 10.1111/j.1365-2125.1983.tb04988.x
- Ankier, SI;
- Barclay, SP;
- Warrington, SJ
- Article
15
- British Journal of Clinical Pharmacology, 1983, v. 16, n. 2, p. 185, doi. 10.1111/j.1365-2125.1983.tb04983.x
- Dew, MJ;
- Ryder, RE;
- Evans, N.;
- Evans, BK;
- Rhodes, J.
- Article
16
- British Journal of Clinical Pharmacology, 1983, v. 16, n. 2, p. 133, doi. 10.1111/j.1365-2125.1983.tb04976.x
- Rapeport, WG;
- McInnes, GT;
- Thompson, GG;
- Forrest, G.;
- Park, BK;
- Brodie, MJ
- Article
17
- British Journal of Clinical Pharmacology, 1983, v. 16, n. 2, p. 199, doi. 10.1111/j.1365-2125.1983.tb04987.x
- Laurikainen, E.;
- Kanto, J.
- Article